In prostate cancer, tumor-associated macrophages secrete pro-inflammatory cytokines such as CCL2 and CCL5, thus enhancing the migratory ability of prostate cancer cells to other parts of the body, especially the bone. This evidence concerns the gene CCL2 and prostate carcinoma.